Overview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of 4,144,447 shares in Innoviva Inc (NASDAQ:INVA). The transaction, which took place on December 29, 2023, reflects a 3.63% increase from the previous holding, marking a significant vote of confidence in the biopharmaceutical company. With a trade price of $16.04 per share, the firm has demonstrated a strategic move to capitalize on Innoviva's market potential.
Innoviva (NASDAQ:INVA – Get Rating) and Cogent Biosciences (NASDAQ:COGT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk. Analyst Ratings This is a summary of current recommendations for […]
Cogent Biosciences (NASDAQ:COGT – Get Rating) and Innoviva (NASDAQ:INVA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Valuation & Earnings This table compares Cogent Biosciences and Innoviva’s […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner acquired 7,000 shares of the business’s stock in a transaction dated Monday, June 5th. The shares were bought at an average price of $13.04 per share, for a total transaction of $91,280.00. Following the acquisition, the insider now owns 7,207,000 shares of the company’s […]